UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7J7UWB0 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A7J7UWF1 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A671G3S8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A671ETL4 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A671EW66 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A671EP42 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A671DWU1 | Pannexin |
|
1 | 0 |
|
B6ZGN7 | Angiotensin-converting enzyme |
|
5 | 0 |
|
A0A671EF28 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
2 | 0 |
|
A0A671G1N3 | P2X purinoceptor |
|
1 | 0 |
|
B2KIN4 | Cathepsin D |
|
2 | 0 |
|
A0A7J7WRP3 | Pannexin 2 |
|
1 | 0 |
|
A0A7J7ZPZ8 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A671FLJ1 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A7J7W5P9 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A671G5K1 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
A0A7J7WNN1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J7Y6C8 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A7J7UKH9 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
A0A671FG05 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A7J8ATJ8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A671ER02 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
A0A671FCP2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J7TBM2 | Angiotensin-converting enzyme |
|
1 | 0 |
|
A0A671FD56 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024